rns in the Chinese economy, and other information detailed from time
to time in the Company's filings and future filings with the United States
Securities and Exchange Commission. Investors are urged to consider these
factors carefully in evaluating the forward-looking statements herein and
are cautioned not to place undue reliance on such forward-looking
statements, which are qualified in their entirety by this cautionary
statement. The forward-looking statements made herein speak only as of the
date of this press release and the Company undertakes no duty to update any
forward-looking statement to conform the statement to actual results or
changes in the company's expectations.
Company Contact: Investor Relations Contact:
Ms. Melody Shi Mr. Crocker Coulson
CFO President
Shengtai Pharmaceutical, Inc. CCG Elite Investor Relations
Tel: +1-949-468-7078 Tel: +1-646-213-1915 (NY Office)
E-mail: shengtaicfo@hotmail.com E-mail: crocker.coulson@ccgir.com
'/>"/>SOURCE Shengtai Pharmaceutical, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 20082.
DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board3.
Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference4.
Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference5.
Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation6.
Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference7.
Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products8.
A New, Unique and Unrivalled Rat/Mouse PINP Assay for Pharmaceutical, Clinical and Academic Research Organizations.9.
Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference to Webcast Alexzas Corporate Presentation10.
Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference11.
Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference